David Tscharke

28PUBLICATIONS
126CO-AUTHORS
Gene and molecular therapyInnate immunityApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Medical virologyDeep learning
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (28)

|Dec 26, 2025
Study protocol for a multicentre, randomised, double-blinded, placebo-controlled, multi-arm, multi-stage, trial of SpironolacTone and famciclOovir in the treatment of Progressive Multiple Sclerosis to prevent disability progression: the STOP-MS trial.

Kayla Ward, Vivien Li, Sudarshini Ramanathan

|Dec 19, 2025
A poxvirus model reveals general correlates of antigen presentation and immunogenicity for viral CD8+ T cell epitopes.

Matthew J Witney, Nathan P Croft, Yik Chun Wong

|Dec 18, 2025
Convergent mutation trajectories convert functional self-tolerance in IGHV4-34 B cells to genetic tolerance encoded in the antibody.

Christopher J Jara, Sherin Zachariah, Katherine J L Jackson

|Mar 26, 2025
Herpes simplex virus type 1 impairs mucosal-associated invariant T cells.

Lauren Stern, Zoe Emanuel, Renee Traves

|Jan 10, 2025
Repurposing Licensed Drugs with Activity Against Epstein-Barr Virus for Treatment of Multiple Sclerosis: A Systematic Approach.

Vivien Li, Fiona C McKay, David C Tscharke

|Oct 21, 2024
Lytic promoter activity during herpes simplex virus latency is dependent on genome location.

Navneet Singh, Sherin Zachariah, Aaron T Phillips

Pageof 5

Frequent Collaborators

5 joint publications

Nathan P Croft

5 joint publications

Anthony W Purcell

3 joint publications

Gregory Moseley

3 joint publications

Jason Mackenzie